In summary, the current study indicates that the increased Nrf2 levels could stimulate FPN transcriptional expression, leading to the reduction of intracellular ferritins and the suppression of the cell proliferation, migration and mitosis of prostate cancer cells. The gene discussed is SLC40A1; the disease is prostate cancer.